ReviewNanotheranostics2025
Advancements in SERS: Revolutionizing Biomedical Analysis and Applications.
Review in Nanotheranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Breaking Biological Barriers: Engineering Nanocarriers for Efficient Drug and Gene Delivery through Nano-Bio Interfaces and Biophysical Design.Applied physics reviews · 2026Article
- Advances and Prospects of Chiral Plasmonic Nanomaterials in Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Research progress of AI assisted nano-SERS technology in rapid identification of multi species oral pathogenic biofilms.Mikrochimica acta · 2026Review
- Plasmonic Nanoarray Biosensors for Non-Invasive Cancer Diagnostics.Biosensors · 2026Review
- Gold- or Silver-Nanoparticle SERS Platforms for Plasma-Based Diagnostics and AI-Driven Analysis.Sensors (Basel, Switzerland) · 2026Review
- Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration.Molecules (Basel, Switzerland) · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-enhanced Raman scattering (SERS) has emerged as a powerful technique for bioanalysis, offering ultrasensitive molecular detection and identification capabilities. The signal intensity and reproducibility of Raman responses from analytes are primarily influenced by the surface roughness and nanogap architecture of plasmonic materials. Numerous designs, plasmonic nanostructures, and fabrication methods have been explored to optimize these factors. The precise nanogap ranging from 0.5 to 1.0 nm between the metallic nanoparticles and analytes offers significantly higher Raman enhancement, enabling single-molecule detection through SERS. With advancements in nano- and microfabrication techniques, the development of highly efficient SERS substrates has significantly enhanced the analytical performance in various biomedical applications. This review comprehensively examines the latest innovations in nano- and microfabricated SERS sensors, emphasizing their design, fabrication techniques, and functionalization strategies for biomolecular detection, bioimaging, and theranostic applications. Furthermore, we explore the growing role of artificial intelligence (AI) in optimizing SERS-based bioanalysis, from enhancing spectral data processing to developing machine learning models for pattern recognition and diagnostic applications. The integration of AI with SERS technologies holds great promise for revolutionizing point-of-care diagnostics, real-time biomarker monitoring, and personalized medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.